Trametinib 2mg tabs, 30 ct, $40

Trametinib is a treatment that targets specific mutations in melanoma and NSCLC. It’s like a MEK inhibitor, which stops cancer cells from growing and spreading by blocking a key signal pathway. You can get this drug in two strengths: 0.5 mg and 2 mg in a tablet form.

The usual dose for adults and teens 12 and up with BRAF V600E melanoma or advanced NSCLC is 2 mg once a day, best on an empty stomach. It comes in bottles with 30 tablets, and the 0.5 mg usually costs less because it’s weaker and there are fewer tablets in each bottle.